| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |